Intensive Care Medicine

, Volume 21, Issue 11, pp 933–936 | Cite as

The impact of HIV testing on blood utilization in the intensive care unit in patients with gastrointestinal bleeding

  • M. R. Ravry
  • H. L. Paz
Original

Abstract

Objective

To determine whether the AIDS epidemic has influenced physician use of blood products in intensive care unit management of gastrointestinal hemorrhage.

Methods

Retrospective chart review of 148 patients with gastrointestinal hemorrhage admitted to the intensive care unit. Forty-eight patients were admitted before the onset of HIV testing of the blood supply (group 1) and 100 were admitted after HIV testing was begun (group 2).

Results

Of the 148 patients, 18 (eight in group 1, ten in group 2) were not transfused and had higher median hemoglobin levels on admission and higher median hemoglobin nadirs during hospitalization than patients who were transfused. Transfused patients in group 3 did not have significantly lower median hemoglobin levels on admission (7.9 (4.2–12.5) g/dl) than transfused patients in group 1 (9.3 (4.1–13.5) g/dl) (p=0.058). Patients in group 2 had significantly lower median hemoglobin concentrations prior to the first transfusion event (7.4 (4.2–10.3) g/dl) than those in group 1 (8.5 (4.2–12.1) g/dl) (p=0.016). There were no significant differences between the two groups in terms of the total number of units of packed red blood cells, fresh frozen plasma or platelets transfused. Neither was any significant difference in mortality observed, with 11 patients (22.9%) dying in group 1 and 23 patients (23.0%) dying in group 2. The cause of death in 13 of the 34 patients was related to cardiovascular and hemodynamic complications of gatrointestinal bleeding. There was no significant difference in mean age (group 1: 60.5 years, group 2: 59.4 years) or mean hemoglobin nadir (group 1: 7.0 g/gl, group 2: 7.1 g/dl) among those who died in the two groups.

Conclusions

These data indicate that physicians are transfusing patients at lower hemoglobin levels than they did before the beginning of HIV testing. However, there has been no decrease in the total median amount of blood products transfused since that time. This change in practice may be due to increased concern about HIV transmission through blood products and suggests the need for greater awareness of existing transfusion guidelines.

Key words

Resource utilization Clinical outcomes Gastrointestinal bleeding Blood product transfusion HIV Intensive care 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blair SD, Janvrin SB, McCollum CN et al (1986) Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg 73: 783–785Google Scholar
  2. 2.
    Hosgood G (1990) Blood transfusion: a historical review. J Am Vet Med Assoc 197: 998–1000Google Scholar
  3. 3.
    henriksson AE, Svensson JO (1991) Upper gastrointestinal bleeding with special reference to blood transfusion. Eur J Surg 157: 193–196Google Scholar
  4. 4.
    Palmer ED (1970) Immediate management. In: Thomas CC (ed) Upper Gastrointestinal Hemorrhage. Thomas, Springfield, Ill, pp 91–92Google Scholar
  5. 5.
    Sherman L (1988) The implications of trends in transfusion. Transfusion 28: 511–512Google Scholar
  6. 6.
    Surgenor DM, Wallace EL, Hao SH et al (1990) Collection and transfusion of blood in the United States, 1982–1988. N Engl J Med 322: 1646–1651Google Scholar
  7. 7.
    Downs M, Ancelle-Park RA, Costagliola D et al (1991) Transfusion-associated AIDS cases in Europe: estimation of the incubation period, distribution and prediction of future cases. J Acquir Immune Defic Syndr 4: 805–813Google Scholar
  8. 8.
    Menitove JE (1991) Transfusion practices in the 1990s. Annu Rev Med 42: 297–309Google Scholar
  9. 9.
    Cane RD (1990) Hemoglobin: how much is enough? Crit Care Med 18: 1046–1047Google Scholar
  10. 10.
    Welch HG, Meehan KR, Goodnough LT (1992) Prudent strategies for elective red blood cell transfusion. Ann Intern Med 116: 393–402Google Scholar
  11. 11.
    American College of Physicians (1992) Practice strategies for elective red blood cell transfusion. Ann Intern Med 116: 403–406Google Scholar
  12. 12.
    Hunt PS, Hansky J, Korman MG (1979) Mortality in patients with haematemesis and melaena: a prospective study. Br Med J 1: 1238–1240Google Scholar
  13. 13.
    Hunt PS, Korman MG, Hansky J et al (1979) Bleeding duodenal ulcer: reduction in mortality with a planned approach. Br J Surg 66: 633–635Google Scholar
  14. 14.
    Rofe SB, Duggan JM, Smith ER et al (1985) Conservative treatment of gastrointestinal hemorrhage. Gut 26: 481–484Google Scholar
  15. 15.
    Office of Medical Applications of Research, National Institutes of Health (1988) Perioperative red cell transfusion. JAMA 260: 2700–2703Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • M. R. Ravry
    • 1
    • 2
  • H. L. Paz
    • 1
    • 2
  1. 1.Center for Clinical OutcomesHahnemann UniversityPhiladelphiaUSA
  2. 2.Division of Critical Care and Pulmonary Medicine, Department of MedicineHahnemann UniversityPhiladelphiaUSA

Personalised recommendations